PubRank
Search
About
Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
Clinical Trial ID NCT01711515
PubWeight™ 14.56
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01711515
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy.
Oncoimmunology
2014
1.22
2
Combinations of immunotherapy and radiation in cancer therapy.
Front Oncol
2014
1.01
3
Immunologic treatments for precancerous lesions and uterine cervical cancer.
J Exp Clin Cancer Res
2014
0.96
4
Emerging biological treatments for uterine cervical carcinoma.
J Cancer
2014
0.95
5
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.
Front Immunol
2015
0.92
6
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment.
Vaccine
2015
0.92
7
Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".
Toxins (Basel)
2014
0.92
8
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
Mod Pathol
2016
0.86
9
Harnessing the immune system to improve cancer therapy.
Ann Transl Med
2016
0.83
10
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
J Gynecol Oncol
2016
0.83
11
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.
Hum Vaccin Immunother
2016
0.82
12
Imaging Biomarkers in Immunotherapy.
Biomark Cancer
2016
0.81
13
Current clinical trials testing the combination of immunotherapy with radiotherapy.
J Immunother Cancer
2016
0.81
14
Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.
Gynecol Oncol
2016
0.79
15
The role of checkpoints in the treatment of GBM.
J Neurooncol
2015
0.75
16
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.
Am Soc Clin Oncol Educ Book
2015
0.75
17
Immunotherapy: New Strategies for the Treatment of Gynecologic Malignancies.
Oncology (Williston Park)
2016
0.75
Next 100